Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urologic Neoplasms 1Urologic Diseases 1Hypogonadism 1

Interventions

Magnetic Resonance Spectroscopy 46Specimen Handling 42Nivolumab 30pembrolizumab 29enzalutamide 28Gemcitabine 24Docetaxel 24apalutamide 20Prednisone 20Biopsy 19cabozantinib 17Abiraterone Acetate 17enfortumab vedotin 15Androgen Antagonists 15abiraterone 14Cisplatin 14darolutamide 13Radiotherapy 13Pluvicto 12Ipilimumab 12Mitomycin 11olaparib 10atezolizumab 10X-Rays 10erdafitinib 9cabazitaxel 9Radiation 9Carboplatin 9belzutifan 8Standard of Care 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Methyltestosterone × Genitourinary × 30 days × Clear all
NCT04731376 2026-05-26

Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone

Emory University

Phase 1 Active not recruiting
56 enrolled
Genitourinary

Hypogonadism, Urologic Diseases, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡